IRF1 mainly functions as a tumor suppressor protein, low-expressing in several human cancers including breast cancer [49], endometrial carcinoma [50], leukemia [51], hepatocellular carcinoma [52] and cholangiocarcinoma [53]. This evidence concerns the gene TCHP and endometrial carcinoma.